Latest updates for Roch:ca
Fresh curated links around ROCH:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Analyst Report: Roche Holding AG
- Roche Holding AG (RHHBY) Q1 2026 Sales/Trading Call Transcript
- Rogers (ROG) Q1 2026 Earnings Call Transcript
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Roche Holding AG (RHHBY) Q1 2026 Sales/Trading Call Transcript
fool.com
/1 month ago
Rogers (ROG) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. DATETuesday, April 28, 2026 at 5 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Ali El-HajChief Financial Officer — Laura RussellNe...
seekingalpha.com
/1 day ago
RBC Canadian Equity Income Fund ETF declares CAD 0.064 dividend
seekingalpha.com
/1 month ago
Reitmans (Canada) Limited 2026 Q4 - Results - Earnings Call Presentation
cantechletter.com
/4 days ago
RBC chops price target on CAE
RBC Dominion Securities analyst James McGarragle lowered his target on CAE (CAE Stock Quote, Chart, News, Analysts, Financials TSX:CAE) to $36.00 from $42.00 in a May 25 update, wh...
seekingalpha.com
/1 week ago
Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation
seekingalpha.com
/3 weeks ago
RB Global expects 2026 GTV growth of 6%-9% while BigIron closing targeted for Q2
pharmexec.com
/1 month ago
<![CDATA[Rocket Pharmaceuticals Enters $180 Definitive Agreement to Sell its Priority Review Voucher ]]>
seekingalpha.com
/3 days ago
ROKT: 3 Current Catalysts That Make Unjustifiable Valuations Justified
seekingalpha.com
/1 month ago
L'Oréal S.A. (LOR:CA) Q1 2026 Sales/Trading Call Transcript
finance.yahoo.com
/1 week ago
Osisko (ODV) Reports 1Q2026 Financial and Operational Results
pharmexec.com
/1 month ago
<![CDATA[Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement ]]>
seekingalpha.com
/1 month ago
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update - Slideshow
seekingalpha.com
/1 month ago
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
seekingalpha.com
/1 month ago
GO Residential Real Estate Investment Trust declares $0.0532 dividend
seekingalpha.com
/1 week ago
Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript
biopharmadive.com
/1 month ago
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Roch:ca
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source
cantechletter.com
Recent coverage from public sources
Public source